pharmaphorum
OCTOBER 6, 2022
An artificial intelligence-powered digital health worker has been unveiled by the World Health Organisation (WHO) as its latest tool for disseminating reliable health information to the public. Originally developed by New Zealand tech company Soul Machines with support of the Qatar Ministry of Health, the first version of the virtual health worker was used to combat misinformation about the pandemic.
MedCity News
OCTOBER 1, 2022
The metaverse holds promising potential to transform healthcare delivery for the better, according to a keynote talk delivered at MedCity’s Invest Digital Health conference. The speaker identified workforce training, patient experience, healthcare facilities and medical manufacturing as the main areas poised for disruption.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaTech
OCTOBER 3, 2022
Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.
PharmaTimes
OCTOBER 4, 2022
Treatment involves adult patients with severe alopecia areata
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
pharmaphorum
OCTOBER 7, 2022
A UK study has found that Merck & Co’s oral COVID-19 therapy Lagevrio was unable to reduce hospitalisations compared to placebo in patients at higher risk from the virus, adding fuel to assertions in some quarters that its authorisation was premature. The 25,000-subject PANORAMIC trial conducted by researchers at Oxford University looked at the addition of a five-day course of Lagevrio (molnupiravir) to standard care in people aged over 50, or adults aged 18 and over with conditions th
MedCity News
OCTOBER 4, 2022
Following a series of violent threats directed at medical centers that care for transgender youth, […].
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaTimes
OCTOBER 1, 2022
Data further supports the continued development of FLU-v as a broad-spectrum influenza vaccine
PharmaTech
OCTOBER 3, 2022
A blended approach to newly revised regulatory guidance to inform environmental monitoring programmes is essential.
MedCity News
OCTOBER 1, 2022
An INVEST Digital Health panel discussion on investment beyond the traditional hubs of venture capital investment, touched on the role of Zoom in making it easier to maintain relationships with startups across the country in places like Indiana, Utah, Colorado and beyond.
Pharmaceutical Technology
OCTOBER 6, 2022
Pfizer has acquired all the outstanding shares of the common stock of biopharmaceutical firm Global Blood Therapeutics (GBT) in a deal worth nearly $5.4bn. The total enterprise value comprised debt and the net of cash acquired. With the latest acquisition, GBT became a wholly-owned Pfizer subsidiary. GBT discovers and develops life-changing therapies for ailments with an initial focus on sickle cell disease (SCD).
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaTimes
OCTOBER 4, 2022
University of Lincoln and the University of Sheffield are researching how DNA could be repaired
pharmaphorum
OCTOBER 3, 2022
Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharma companies’ customer communication methods require reimagining as technology progresses. Kapoor says, now, pharma can learn from the on-demand nature of content distribution that Hollywood utilises and simultaneously prepare for future needs in content delivery. “One of our
MedCity News
OCTOBER 1, 2022
More than 7% of Hispanic Americans have a substance use disorder, but have less access to treatment than non-Hispanic Americans. The Spanish version of the app will provide the same services as English version, but with a focus on challenges experienced by the Latinx community.
Pharmaceutical Technology
OCTOBER 5, 2022
In 2010, two patients with end-stage refractory chronic lymphocytic leukaemia (CLL) were administered Novartis’ autologous anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy, Kymriah (tisagenlecleucel), as part of a Phase I trial. In March this year, it was reported that these two patients were still in remission, making this the longest known CLL remission after CAR-T therapy and demonstrating to the industry that long-term remission is indeed possible.
PharmaTimes
OCTOBER 7, 2022
The companies will aim to improve treatment for patients with prostate, breast and lung cancer
pharmaphorum
OCTOBER 4, 2022
The life sciences company Solid Biosciences is merging with the privately-held gene therapy company AavantiBio in a deal which is expected to result in a combined sum of $215 million in cash and investments – projected to be enough for funding into 2025. AavantiBio, a precision genetic medicine company that was bankrolled by Solid’s rival Sarepta back in 2020, focuses on neuromuscular and cardiac rare diseases.
MedCity News
OCTOBER 5, 2022
One of the most popular analyst terms in 2022, cybersecurity mesh is a defense method for securing each device and critical access points with their own security perimeter. It builds a foundation of dynamic interoperability in the environment, rather than the traditional security protections of a single perimeter.
PharmExec
OCTOBER 4, 2022
Hiring new employees may not be the answer to the war for talent.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
PharmaTimes
OCTOBER 7, 2022
First EU public-private collaboration for production of saRNA-based vaccines
Storyvine
OCTOBER 1, 2022
CHALLENGE. In-person access to Health Care Providers (HCPs) was dramatically reduced due to COVID-19, and pharmaceutical sales reps struggled with gaining access and engagement even as things have “returned to normal.” This lack of face-to-face customer access had the potential to impact revenue, and Novartis wanted an innovative solution that would allow their Sales Associates to improve engagement and drive sales—and it needed to work in their highly-regulated environment.
MedCity News
OCTOBER 4, 2022
Google Cloud unveiled a new product suite to make medical imaging data more interoperable and useful via artificial intelligence. Hackensack Meridian Health has begun using it to detect metastasis in prostate cancer patients earlier, and Hologic is using it to strengthen its diagnostic platform that screens women for cervical cancer.
pharmaphorum
OCTOBER 5, 2022
The US Government’s Biomedical Advanced Research and Development Authority (BARDA) has made an initial investment of approximately $55 million for rapid development of VIR-2482, the Vir Biotechnology’s investigational prophylactic monoclonal antibody (mAb) for seasonal and pandemic influenza viruses. Its purpose being to support pandemic preparedness for influenza and other infectious disease threats, this is the first award from BARDA – part of the US Department of Health and Human Servic
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
PharmaTimes
OCTOBER 6, 2022
The Airport Region in Central Germany’ presents itself as an attractive location for the international pharmaceutical industry
Medgadget
OCTOBER 5, 2022
Imperial College London researchers created a conductive cotton thread that can undergo a computerized embroidery process for incorporation into commercially produced textiles, such as t-shirts and face masks. The thread, called PECOTEX, can be used to create wearable health sensors, such as heart rate monitors, breathing monitors and even gas sensors, including ammonia sensors for the breath, which can provide information on liver and kidney function.
MedCity News
OCTOBER 4, 2022
From July 2021 to July 2022, 1,216 prescription drugs saw price increases that soared past the inflation rate of 8.5% for that time period, one HHS report showed. Another reported that in 2021, the American healthcare system spent $603 billion on prescription drugs, of which $421 billion was spent on retail drugs.
European Pharmaceutical Review
OCTOBER 1, 2022
Bioheng Biotech , a biotechnology firm that develops cellular immunotherapies, have issued key Phase I clinical trial (NCT04538599) results for the drug RD13-01, an anti-CD7 universal CAR-T therapy, establishing that it is safe for use and has the potential to eliminate malignant tumours. It is the first trial to use healthy donor-derived CD7-targeting allogeneic CAR T cells to treat CD7-positive haematological tumours.
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
PharmaTimes
OCTOBER 1, 2022
The research involves patients with advanced solid malignancies on tumour-directed therapy
Medgadget
OCTOBER 3, 2022
A team at the University of Illinois at Urbana-Champaign has developed a DNA net system that can ensnare Sars-CoV-2 and bind to the notorious spike protein. The nets contain aptamers that bind the spike protein and emit an intense fluorescent signal once they’re bound together to the protein. This signal can be easily measured using a handheld fluorimeter.
MedCity News
OCTOBER 4, 2022
There is a dearth of professionals with licenses and training to provide care for seniors’ mental and behavioral health challenges — such as Alzheimer’s and other dementias, anxiety and depression. Seattle-based Rippl Care is seeking to change this. The startup just closed a $32 million seed funding round led by ARCH Venture Partners and General Catalyst.
Pharmaceutical Technology
OCTOBER 4, 2022
Pfizer has acquired commercial-stage biopharmaceutical firm Biohaven Pharmaceutical for $148.50 for each share or a total consideration of nearly $11.6bn in cash. In May, Pfizer entered a definitive agreement to acquire all outstanding shares of Biohaven which were not previously held by the former. . With the takeover, Biohaven became a wholly-owned Pfizer subsidiary.
Expert insights. Personalized for you.
145 
Let's personalize your content